Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
22%(2 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_2
4
29%
Ph not_applicable
1
7%
Ph phase_1
1
7%
Ph phase_3
7
50%
Ph phase_4
1
7%

Phase Distribution

1

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
4(28.6%)
Phase 3Large-scale testing
7(50.0%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(9)
Terminated(2)
Other(3)

Detailed Status

Completed9
unknown3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 24 (28.6%)
Phase 37 (50.0%)
Phase 41 (7.1%)
N/A1 (7.1%)

Trials by Status

unknown321%
completed964%
terminated214%

Recent Activity

0 active trials
Showing 5 of 14
completedphase_3

Alitretinoin in the Treatment of Chronic Hand Eczema

NCT00519675
completedphase_3

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

NCT00124436
completedphase_3

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

NCT00124475
completedphase_3

Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

NCT00309621
completedphase_3

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

NCT00817063
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT00519675Phase 3

Alitretinoin in the Treatment of Chronic Hand Eczema

Completed
NCT00124436Phase 3

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

Completed
NCT00124475Phase 3

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Completed
NCT00309621Phase 3

Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Completed
NCT00817063Phase 3

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

Completed
NCT03026946Phase 3

Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema

Unknown
NCT03026907Phase 3

Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema

Unknown
NCT01245140Phase 2

Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis

Completed
NCT01407679Phase 2

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Terminated
NCT01231854Phase 4

Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.

Terminated
NCT01261923Phase 1

Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease

Completed
NCT01538732Phase 2

Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin

Unknown
NCT00002188Phase 2

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Completed
NCT00002439Not Applicable

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14